Role of Siravedhana (Bloodletting) in the Management of Vatarakta (Gout): A Case Report

Abstract

Background
Vatarakta, a classical Ayurvedic condition arising from mutual obstruction of Vata Dosha and Rakta Dhatu, shares clinical parallels with gout — an inflammatory arthropathy driven by monosodium urate crystal deposition. While Raktamokshana (therapeutic bloodletting) is a cornerstone treatment in Ayurvedic surgery, objective documentation of its outcomes in such conditions remains sparse.
Case Presentation
A 27-year-old male presented with acute pain, swelling, and restricted mobility of the right first metatarsophalangeal (MTP) joint for one week. Laboratory findings revealed elevated serum uric acid (>7 mg/dL), mildly raised ESR, and a mildly elevated RA factor. The clinical presentation was consistent with acute podagra, clinically suspected as Uttana Vatarakta.
Management and Outcome
Siravedhana (therapeutic venesection) was performed in two sittings (Day 0 and Day 7) at the dorsal venous arch of the right foot, proximal to Kshipra Marma (the vital point located in the web space between the first and second metatarsals). Approximately 60–70 mL of blood was withdrawn per sitting using a 20-gauge sterile needle. Pain assessed by Visual Analogue Scale (VAS) decreased from 7/10 to 3/10 (57% reduction). Goniometric assessment of the first MTP joint showed flexion improvement from 25° to 45° (80% increase) and extension from 5° to 15° (200% increase).
Conclusion
Siravedhana demonstrated clinically meaningful improvement in pain and joint mobility within 7 days. However, as acute gout episodes can self-resolve within a similar timeframe, the contribution of treatment versus natural disease resolution cannot be confirmed from a single uncontrolled case. Controlled trials with objective inflammatory biomarkers are warranted.